NCT05146635 2022-01-11
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
Mansoura University
Phase NA Unknown
Mansoura University
Huashan Hospital
National Cancer Institute (NCI)